Learn More
Medchemexpress LLC Trametinib-d4 | 871700-17-3 | 99.87% | 619.42 | 1 MG

Supplier: Medchemexpress LLC HY10999S1MG
This product is a stable isotope-labeled compound, specifically a deuterium-labeled version of a MEK inhibitor. It is an orally active inhibitor that targets MEK1 and MEK2, demonstrating activity at very low concentrations. The compound is noted for its ability to activate autophagy and induce apoptosis. It is intended for research use only and not for human therapeutic applications.
- Features
- Deuterium labeled compound.
- Targets MEK1 and MEK2 with high potency.
- Activates autophagy.
- Induces apoptosis.
- Oral activity.
- Benefits
- Can be used as a tracer in research.
- Serves as an internal standard for quantitative analysis using techniques like NMR, GC-MS, or LC-MS.
- Deuterium substitution may influence pharmacokinetic and metabolic profiles of drugs.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.